A carregar...
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
Rationale: Two antifibrotic medications, nintedanib and pirfenidone, have been approved for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States. Few data have been published on the use of these medications in clinical practice. Objectives: To investigate patterns of use of anti...
Na minha lista:
| Publicado no: | Ann Am Thorac Soc |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Thoracic Society
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640723/ https://ncbi.nlm.nih.gov/pubmed/32574517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201912-880OC |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|